Get started
MEDITE CANCER DIAGNOSTICS INCMEDITE CANCER DIAGNOSTICS INCMEDITE CANCER DIAGNOSTICS INC

MEDITE CANCER DIAGNOSTICS INC

No trades
See on Supercharts
Overview
Financials Ideas Discussions Technicals Seasonals

MDIT chart


Full chart

MDIT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
86.00 USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪77.86 M‬
Beta (1Y)
32.20

About MEDITE CANCER DIAGNOSTICS INC


Sector
Health Technology
Industry
Medical Specialties
Headquarters
Orlando
Website
medite-group.com
Founded
1998
FIGI
BBG000P43F88
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. The firm specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland. The company was founded in December 1998 and is headquartered in Orlando, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MDIT is 0.000001 USD — it hasn't changed in the past 24 hours. Watch MEDITE CANCER DIAGNOSTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MEDITE CANCER DIAGNOSTICS INC stocks are traded under the ticker MDIT.
MDIT stock has fallen by −99.00% compared to the previous week, the last month showed zero change in price, over the last year MEDITE CANCER DIAGNOSTICS INC has showed a −99.00% decrease.
MDIT reached its all-time high on May 10, 1983 with the price of 37,000.000000 USD, and its all-time low was 0.000001 USD and was reached on Dec 22, 2021. View more price dynamics on MDIT chart.
See other stocks reaching their highest and lowest prices.
MDIT stock is 0.00% volatile and has beta coefficient of 32.20. Track MEDITE CANCER DIAGNOSTICS INC stock price on the chart and check out the list of the most volatile stocks — is MEDITE CANCER DIAGNOSTICS INC there?
Yes, you can track MEDITE CANCER DIAGNOSTICS INC financials in yearly and quarterly reports right on TradingView.
MEDITE CANCER DIAGNOSTICS INC is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
No, MDIT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MDIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDITE CANCER DIAGNOSTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDITE CANCER DIAGNOSTICS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDITE CANCER DIAGNOSTICS INC stock shows the sell signal. See more of MEDITE CANCER DIAGNOSTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.